All US holdings of this investor are reported in this report. Top holdings included DEN, EQT, SM, DVN, and CTRA. Confidential Treatment Requested (one or more holding(s) omitted).
Filing 2021 Q4 compared to 2021 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Megan Croal
Chief Compliance Officer
Chicago, Illinois
10 Feb 2022
The following information corresponds to the securities indicated in the attached Information Table: (A) Includes 2,737,616 Restricted Stock Units that represents a right to receive one share of EQT Corporation common stock.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.